Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werner Aberer

Showing results (61-70 of 161) with videos related to

Pageof 17
Sort By:
Clinical and Translational Allergy|March 31, 2018
Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational studyTeresa Caballero, Andrea Zanichelli, Werner Aberer, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|April 27, 2016
The Icatibant Outcome Survey: treatment of laryngeal angioedema attacksHilary J Longhurst, Werner Aberer, Laurence Bouillet, et al.
Wiener Klinische Wochenschrift|September 9, 2011
[Clinical practise guideline of the special interest group in allergy of the ÖGDV - Drug provocation testing in the diagnosis of cutaneous drug reactions]Birger Kränke, Werner Aberer, Cornelia Egger, et al.
Cytometry. Part B, Clinical Cytometry|June 10, 2010
CD203c-based basophil activation test in allergy diagnosis: characteristics and differences to CD63 upregulationEva M Sturm, Bettina Kranzelbinder, Akos Heinemann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 4, 2007
Contact dermatitisJochen Brasch, Detlef Becker, Werner Aberer, et al.
Allergy and Asthma Proceedings|August 29, 2015
Analysis of characteristics associated with reinjection of icatibant: Results from the icatibant outcome surveyHilary J Longhurst, Werner Aberer, Laurence Bouillet, et al.
Wiener Klinische Wochenschrift|December 18, 2010
Histamine intolerance: lack of reproducibility of single symptoms by oral provocation with histamine: a randomised, double-blind, placebo-controlled cross-over studyPeter Komericki, Georg Klein, Norbert Reider, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 4, 2022
Tolerability and Cross-reactivity of 3 New Hair Colorants in p-Phenylenediamine-Allergic IndividualsLukas Koch, Karin Plaschg, Anne Fuchs, et al.
The Journal of Allergy and Clinical Immunology|July 17, 2012
Ves v 5 can establish the diagnosis in patients without detectable specific IgE to wasp venom and a possible north-south difference in Api m 1 sensitization in EuropeGunter J Sturm, Maria Beatrice Biló, Patrizia Bonadonna, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 16, 2016
Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical settingAndrea Zanichelli, Hilary J Longhurst, Marcus Maurer, et al.
Pageof 17

Showing results (61-70 of 161) with videos related to

Sort By:
Pageof 17
Clinical and Translational Allergy|March 31, 2018
Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational studyTeresa Caballero, Andrea Zanichelli, Werner Aberer, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|April 27, 2016
The Icatibant Outcome Survey: treatment of laryngeal angioedema attacksHilary J Longhurst, Werner Aberer, Laurence Bouillet, et al.
Wiener Klinische Wochenschrift|September 9, 2011
[Clinical practise guideline of the special interest group in allergy of the ÖGDV - Drug provocation testing in the diagnosis of cutaneous drug reactions]Birger Kränke, Werner Aberer, Cornelia Egger, et al.
Cytometry. Part B, Clinical Cytometry|June 10, 2010
CD203c-based basophil activation test in allergy diagnosis: characteristics and differences to CD63 upregulationEva M Sturm, Bettina Kranzelbinder, Akos Heinemann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 4, 2007
Contact dermatitisJochen Brasch, Detlef Becker, Werner Aberer, et al.
Allergy and Asthma Proceedings|August 29, 2015
Analysis of characteristics associated with reinjection of icatibant: Results from the icatibant outcome surveyHilary J Longhurst, Werner Aberer, Laurence Bouillet, et al.
Wiener Klinische Wochenschrift|December 18, 2010
Histamine intolerance: lack of reproducibility of single symptoms by oral provocation with histamine: a randomised, double-blind, placebo-controlled cross-over studyPeter Komericki, Georg Klein, Norbert Reider, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 4, 2022
Tolerability and Cross-reactivity of 3 New Hair Colorants in p-Phenylenediamine-Allergic IndividualsLukas Koch, Karin Plaschg, Anne Fuchs, et al.
The Journal of Allergy and Clinical Immunology|July 17, 2012
Ves v 5 can establish the diagnosis in patients without detectable specific IgE to wasp venom and a possible north-south difference in Api m 1 sensitization in EuropeGunter J Sturm, Maria Beatrice Biló, Patrizia Bonadonna, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 16, 2016
Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical settingAndrea Zanichelli, Hilary J Longhurst, Marcus Maurer, et al.
Pageof 17